Although the world is becoming mostly sedentary, our bodies still require a wide variety of daily movements in order to work well. Many of us struggle to get regular exercise, but even that can fall short of nourishing the body from head to toe. How can we move more—a lot more—when we have sore, stiff parts and overly busy lifestyles? Join Katy Bowman M.S., biomechanist, author, and movement educator as she combines big-picture lessons on biomechanics, kinesiology, physiology, and natural hu ...
…
continue reading
Content provided by AUAUniversity and American Urological Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AUAUniversity and American Urological Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice
MP3•Episode home
Manage episode 378032510 series 2497848
Content provided by AUAUniversity and American Urological Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AUAUniversity and American Urological Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice CME Available: https://auau.auanet.org/node/39292 Release Date: September, 2023 Expiration Date: September, 2024 After participating in this educational activity, participants will be able to: 1. Cite recommendations within the newly amended AUA/SUO Advanced Prostate Cancer Guideline. 2. Assess the impact of newly approved agents on the management of men with Advanced Prostate Cancer. 3. Define M0 CRPC and the treatment options. 4. Identify clinically meaningful endpoints in clinical trials of patients with M0 CRPC. 5. Describe gaps in the knowledge for treatment and sequencing of agents in the management of CRPC. 6. Discuss treatment intensification in mHSPC. 7. Discuss challenges in incorporating AUA/SUO Advanced Prostate Cancer Guideline and management of advanced mHSPC and CRPC into community practice. ACKNOWLEDGEMENTS This educational series is supported by independent educational grants from: • Astellas and Pfizer, Inc. • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC • Lantheus Medical Imaging • Merck & Co., Inc. • Pfizer, Inc.
…
continue reading
348 episodes
MP3•Episode home
Manage episode 378032510 series 2497848
Content provided by AUAUniversity and American Urological Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AUAUniversity and American Urological Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice CME Available: https://auau.auanet.org/node/39292 Release Date: September, 2023 Expiration Date: September, 2024 After participating in this educational activity, participants will be able to: 1. Cite recommendations within the newly amended AUA/SUO Advanced Prostate Cancer Guideline. 2. Assess the impact of newly approved agents on the management of men with Advanced Prostate Cancer. 3. Define M0 CRPC and the treatment options. 4. Identify clinically meaningful endpoints in clinical trials of patients with M0 CRPC. 5. Describe gaps in the knowledge for treatment and sequencing of agents in the management of CRPC. 6. Discuss treatment intensification in mHSPC. 7. Discuss challenges in incorporating AUA/SUO Advanced Prostate Cancer Guideline and management of advanced mHSPC and CRPC into community practice. ACKNOWLEDGEMENTS This educational series is supported by independent educational grants from: • Astellas and Pfizer, Inc. • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC • Lantheus Medical Imaging • Merck & Co., Inc. • Pfizer, Inc.
…
continue reading
348 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.